The financials
Envista Holdings Corporation by the numbers
Envista Holdings Corporation (NVST) reported revenue of $706M in Q1 2026 (quarter ended April 3, 2026), up 14% from the same quarter a year earlier. That came with a gross margin of 55% and net income of $39M (5.5% of revenue). For the full year FY2025, revenue was $2.72B (+8.3% year on year) and net income $47M. Its largest region in 2026-Q2 was North America at $185M, 39% of the disclosed total, just ahead of Western Europe at 28%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $706M | $617M | +14% |
| Gross profit | $390M | $336M | +16% |
| Operating income | $63M | $39M | +60% |
| Net income | $39M | $18M | +115% |
| Diluted EPS | $0.23 | $0.10 | +130% |
| Geographic | Revenue | Share |
|---|---|---|
| North America | $185M | 39% |
| Western Europe | $133M | 28% |
| High Growth Markets | $129M | 27% |
| Other Developed Markets | $24M | 5.2% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q2 2026Total $471.0M (+2.9%)
Other Developed Markets grew +11% year on yearNorth America +1.5% year on year
Segment Latestquarter on quarteryear on year
- North America$184.7M$184.7MQoQ -2.5%year on year +1.5%-2.5%+1.5%
- Western Europe$133.2M$133.2MQoQ -14%year on year +7.1%-14%+7.1%
- High Growth Markets$128.7M$128.7MQoQ +41%year on year +10%+41%+10%
- Other Developed Markets$24.4M$24.4MQoQ +5.6%year on year +11%+5.6%+11%
Medical Instruments & Supplies
Ranks #8 of 27 by Smart Score